The mouse 5-hydroxytryptamine 4(a) receptor [5-HT %(a) ] was expressed with a baculovirus system in insect cells and analysed for acylation. [$H]Palmitic acid was effectively incorporated into 5-HT %(a) and label was sensitive to the treatment with reducing agents indicating a thioester-type bond. Analysis of proteinbound fatty acids revealed that 5-HT %(a) contains predominantly palmitic acid. Treatment of infected Sf 9 (Spodoptera frugiperda) cells with 
INTRODUCTION
The covalent attachment of fatty acids to proteins (acylation) is a widespread modification of both cellular and viral polypeptides [1] [2] [3] . Two main modes of acylation have been described : Nmyristoylation and palmitoylation (S-acylation). N-myristoylation is a co-translational modification catalysed by N-myristoyltransferase, which modifies a glycine residue within a consensus sequence at the protein N-terminus via an amide linkage [4, 5] . In contrast with myristoylation, the addition of long-chain fatty acids (mainly palmitic acid) is a posttranslational event that occurs through the covalent linkage of palmitate via a labile thioester bond to cysteine residues [6] . Among the cellular palmitoylated proteins, polypeptides involved in signal transduction [e.g. G-protein-coupled receptors (GPCRs), G-protein α-subunits and adenylate cyclases] are prevalent. GPCRs are often palmitoylated on cysteine residues located at the boundary between the seventh transmembrane region and the cytoplasmic tail. Although there is no clear consensus sequence for the acylation of integral membrane proteins, it has been suggested that the signals for palmitoylation comprise a complex conformational nature and are located mainly within the transmembrane domain [7, 8] .
With the finding that palmitoylation is a dynamic process it is now widely accepted that repeated cycles of palmitoylation and depalmitoylation could be involved in the regulation of signalling processes [9] [10] [11] . In GPCRs the functions of palmitoylation cover a wide spectrum of biological activities : from regulated endocytosis to receptor phosphorylation and desensitization [9, 10, 12] . For example, prevention of palmitoylation of the β-Abbreviations used : 5-HT 4(a) , mouse 5-hydroxytryptamine 4(a) receptor ; β 2 AR, β 2 -adrenergic receptor ; BIMU8, (endo-N-8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-2,3-dehydro-2-oxo-3-(prop-2-yl)-1H-benzimid-azole-1-carboxamide ; GR113808A, o1-[2-(methylsulphonylamino)ethyl]-4-piperidinylqmethyl-1-methyl-1-H-indole-3-carboxylate, maleate salt ; GPCRs, G-protein-coupled receptors. 1 To whom correspondence should be addressed (e-mail d.richter!gwdg.de).
of 5-HT %(a) palmitoylation. Incorporation studies revealed that the rate of palmitate incorporation was increased approx. 3-fold after stimulation with agonist. Results of pulse-chase experiments show that activation with BIMU8 promoted the release of radiolabel from 5-HT %(a) , thereby reducing the levels of receptorbound palmitate to approximately one-half. Taken together, our results demonstrate that palmitoylation of 5-HT %(a) is a reversible process and that stimulation of 5-HT %(a) with agonist increases the turnover rate for receptor-bound palmitate. This provides evidence for a regulated cycling of receptor-bound palmitate and suggests a functional role for palmitoylation\depalmitoylation in 5-hydroxytryptamine-mediated signalling.
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adrenergic receptor causes an increased basal phosphorylation and rapid desensitization in response to ligand binding [13] . The long-term stimulation of the β # -adrenergic receptor with agonist, which promotes receptor phosphorylation, also increases receptor depalmitoylation, resulting in decreased signalling through the receptor [14] . A mutation of the corresponding palmitoylation site in the α A# -adrenergic receptor completely abolishes the down-regulation of this receptor during prolonged exposure to agonist [15] . In addition, the activation of α-adrenergic and β-adrenergic receptors itself modulates the palmitoylation of receptor-coupled G-proteins [16] [17] [18] . Removal of the palmitoyl anchors from the rhodopsin C-terminus impairs its stimulatory activity towards all-trans-retinal, suggesting the involvement of palmitoylation in dark adaptation [19] . These results show that palmitoylation can modulate different biological activities of receptors, although it seems that there is no common function applicable to all GPCRs. An analysis of the functions of palmitoylation is therefore necessary for an understanding of the signalling mechanisms of individual receptors.
5-Hydroxytryptamine is a neuromodulator involved in a wide range of physiological functions via the activation of a large family of receptors. With the exception of the 5-HT $ receptor, which is a cation channel, all other 5-hydroxytryptamine receptors are members of the superfamily of seven transmembrane-spanning GPCRs. The 5-HT % receptor is expressed in a wide variety of tissues, including brain, gastrointestinal tract and heart [20, 21] . In the mammalian brain the 5-HT % receptor contributes to the control of dopamine secretion and regulates learning and long-term memory [22, 23] . Furthermore, the 5-HT % receptor is thought to be involved in various central and peripheral disorders, including neurodegenerative disease [24] . The 5-HT % receptor is positively coupled to adenylate cyclase, increasing cAMP levels and leading to the phosphorylation of a number of target proteins [25] . The broad distribution of 5-HT % receptors is paralleled by the existence of various 5-HT % splicing variants. Functional expression has been reported for five C-terminal variants and one internal splice variant in humans [26] . In addition, four 5-HT % receptor isoforms, 5-HT %(a) , 5-HT %(b) , 5-HT %(e) and 5-HT %(f) , were cloned in mouse [27] . All of these variants except the internal splice product in humans share the same sequence up to Leu-358 followed by unique C-termini.
In the present study we investigated fatty acylation of the mouse 5-HT % receptor. After expression of the recombinant receptor in insect Spodoptera frugiperda (Sf 9) cells and immunoprecipitation with newly developed antibodies that specifically recognize the 5-HT %(a) isoform, we show that this receptor contains covalently bound palmitic acid. The cleavage of fatty acids after treatment with hydroxylamine and 2-mercaptoethanol indicates that palmitate is attached in an S-ester-type linkage. By the use of pulse-labelling and pulse-chase labelling we show that the palmitoylation of the 5-HT %(a) receptor is a reversible process. We also report that the exchange of palmitate bound to 5-HT %(a) is accelerated after exposure to the receptor-specific agonist
EXPERIMENTAL

Materials
[9,10-$H(N)]Palmitic acid (30-60 Ci\mmol) was purchased from Hartmann Analytic GmbH (Braunschweig, Germany) ; Tran$&S-label (more than 1000 Ci\mmol) was from ICN (Eschwege, Germany). Enzymes used in molecular cloning were obtained from New England Biolabs (Schwalbach, Germany). 5-Hydroxytryptamine and Protein A-Sepharose CL-4B beads were from Sigma (Deisenhofen, Germany), o1-[2-(methylsulphonylamino)-ethyl]-4-piperidinylqmethyl-1-methyl-1-H-indole-3-carboxylate, maleate salt (GR113808A) was a gift from Glaxo Wellcome (Stevenage, Herts., U.K.). BIMU8 was kindly provided by Boehringer (Ingelheim, Germany). TC-100 insect cell medium, Cellfectin2 Reagent and fetal calf serum were purchased from Life Technologies (Eggenstein-Leopoldshafen, Germany) ; TC-100 medium without -methionine and -glutamine was from PAN Biotech GmbH (Aidenbach, Germany). Cell culture dishes were purchased from Nunc (Wiesbaden, Germany). Oligonucleotide primers were synthesized by Gibco BRL (Karlsruhe, Germany). A polyclonal antiserum, designated AS9459, was raised against a peptide containing amino acid residues 364-380 (CHSGHHQELEKLPIHNDP ; single-letter amino acid codes) corresponding to the deduced C-terminus of 5-HT %(a) . The peptide was purified by HPLC, coupled to keyhole-limpet haemocyanin, mixed with Freund's complete adjuvant and used for the first injection into the rabbit. Second and third injections of peptide mixed with Freund's incomplete adjuvant were performed at 4 week intervals. Serum collected 4 weeks after the third injection was used for immunoprecipitation and immunofluorescence at dilutions of 1 : 60 and 1 : 200 respectively.
Construction of recombinant baculovirus
All basic DNA procedures were as described by Sambrook et al. [28] . The gene encoding 5-HT %(a) was kindly provided by Dr Aline Dumuis (Montpellier, France). The cDNA for 5-HT %(a)
was cleaved with XbaI and HindIII endonucleases to yield a 1.1 kb fragment containing the entire coding sequence. The fragment was ligated to the XbaI and HindIII sites in the multiple cloning site of the pFastBac donor plasmid (Life Technologies). The resulting plasmid was transfected into DH10Bac Escherichia coli cells containing bacmid and helper DNA. Recombinant bacmid DNA was then purified, checked for the presence of the gene encoding 5-HT %(a) by PCR with receptor-specific primers and transfected into Sf 9 cells with Cellfectin reagent. Finally, the recombinant virus was purified and amplified as described previously [29] .
Metabolic labelling and immunoprecipitation
Sf 9 cells were grown in TC-100 medium supplemented with 10 % (v\v) fetal calf serum and 1 % (w\v) penicillin\streptomycin (complete TC-100). For expression, Sf 9 cells (1.5i10') grown in 3.5 mm dishes were infected with recombinant baculovirus encoding 5-HT %(a) at a multiplicity of infection of 10 plaqueforming units per cell. After 48 h, Sf 9 cells were labelled with Tran$&S-label (50 µCi\ml in TC-100 medium without methionine) or [$H]palmitic acid (300 µCi\ml in TC-100 medium, 30-60 Ci\mmol) for the periods indicated in figure legends. For the pulse-chase experiments, cells were subsequently incubated with complete TC-100 medium supplemented with 100 µM unlabelled palmitate and 5 mM sodium pyruvate. In some experiments, BIMU8 and GR113808A were added to the final concentrations indicated in figure legends. To block protein synthesis, cycloheximide (50 µg\ml) was added 10 min before incubation with [$H]palmitate or [$&S]methionine. After labelling (or chase), cells were washed once with ice-cold PBS [140 mM NaCl\3 mM KCl\2 mM KH # PO % \6 mM Na # HPO % (pH 7.4)] and lysed in 600 µl of NTEP buffer [0.5 % (v\v) Nonidet P40\150 mM NaCl\50 mM Tris\HCl (pH 7.9)\5 mM EDTA\ 10 mM iodoacetamide\1 mM PMSF]. Insoluble material was pelleted (5 min, 20 000 g) and antibodies AS9459 raised against the C-terminal peptide of 5-HT %(a) (CHSGHHQELEKLPIH-NDP) were added to the resulting supernatant at a dilution of 1 : 60. After agitation overnight at 4 mC, 30 µl of Protein ASepharose CL-4B was added, and samples were incubated with gentle rocking for 2 h. After a brief centrifugation, the pellet was washed twice with ice-cold NTEP buffer and the immunocomplexes were released from the beads by incubation for 30 min at 37 mC in non-reducing electrophoresis sample buffer [62.5 mM Tris\HCl, pH 6.8, containing 20 % (v\v) glycerol, 6 % (w\v) SDS and 0.002 % Bromophenol Blue]. Radiolabelled polypeptides were analysed by SDS\PAGE [12 % (w\v) gel] and detected by fluorography with Kodak X-Omat AR films. Densitometric analysis of fluorograms was performed with Gel-Pro Analyzer software, version 3.1.
Treatment with hydroxylamine
SDS-containing gels containing 5-HT %(a) labelled with [$H]-palmitic acid were fixed [10 % (v\v) acetic acid\10 % (v\v) methanol] and then soaked in water for 30 min. They were then treated overnight, under gentle agitation, with 1 M hydroxylamine, pH 7.5, or 1 M Tris\HCl, pH 7.5. The gels were washed in water and then rocked for 30 min in DMSO to wash out cleaved fatty acids. The gels were again soaked twice in water for 30 min to remove DMSO, then processed for fluorography.
Fatty acid analysis
[$H]Palmitate-labelled 5-HT %(a) was purified by immunoprecipitation and subjected to SDS\PAGE and fluorography. Regulated palmitoylation of mouse 5-hydroxytryptamine 4(a) receptor
The acyl protein band was excised from the gel, soaked in water twice for 30 min and then dried under vacuum in a desiccator. Fatty acids were cleaved by treatment of the dried gel slices with 6 M HCl for at least 16 h at 110 mC in tightly sealed ampoules. Fatty acids were then extracted three times with hexane ; the upper phases were pooled and concentrated. Separation into individual fatty acid species was performed on RP-18 TLC plates (Merck) with acetonitrile\acetic acid (1 : 1, v\v) as the mobile phase. Radiolabelled fatty acids were detected by fluorography after the plates had been sprayed with En$Hance (DuPont) 
Indirect immunofluorescence
At 48 h after infection with recombinant 5-HT %(a) baculovirus or with wild-type baculovirus, Sf 9 cells grown on coverslips were fixed with paraformaldehyde [3 % (w\v) in PBS] for 15 min. The cells were washed three time with PBS and unreacted paraformaldehyde was quenched with 100 mM glycine for 15 min. Cells were permeabilized with
RESULTS
Detection of 5-HT 4(a) by anti-peptide antibody
To examine post-translational modifications of 5-HT %(a) , antibodies against a synthetic peptide corresponding to its C- terminus-specific sequence (His-364 to Pro-380) were generated in rabbits. High-titre baculovirus stock containing the cDNA of the 5-HT %(a) isoform was prepared as described in the Experimental section and used to infect Sf9 cells. To monitor the expression and intracellular distribution of the receptor, infected Sf 9 cells were first subjected to immunofluorescence. The results in Figure 1(A) show that 5-HT %(a) was specifically detected with the newly developed antibodies and was exposed mainly on the cell surface. As seen in Figure 1 (B), labelling with [$&S]methionine followed by immunoprecipitation and SDS\PAGE analysis revealed a single protein band with a molecular mass of approx. 42 kDa, which corresponds to the predicted molecular mass of the 5-HT % receptor. No specific bands were found in immunoprecipitates of non-infected Sf 9 cells or of Sf 9 cells infected with the wild-type baculovirus ( Figure 1B, left panel) . This emphasizes that the immunoprecipitated 42 kDa protein shown in Figure  1 (B) was indeed 5-HT %(a) . In addition, the functional expression of 5-HT %(a) in Sf 9 cells was confirmed by several assays including coupling to co-expressed G-proteins as well as the modulation of a cyclic-nucleotide-activated and voltage-activated ion channel by receptor agonists (results not shown).
Palmitoylation of 5-HT 4(a)
To examine whether to distinguish between amide-type and ester-type fatty acid linkages. In contrast with the amide bond linkage, the S-ester and hydroxyester linkages are sensitive to the presence of 2-mercaptoethanol [30] . Moreover, the S-ester bond can be distinguished from the hydroxyester by its sensitivity to treatment with hydroxylamine [31] . To investigate whether the fatty acid was attached to 5-HT %(a) by an S-ester bond, proteins labelled with [$H]palmitic acid were subjected to treatment with 2-mercaptoethanol. The results in Figure 2 (A) show that [$H]-palmitate-derived radioactivity bound to the protein was sensitive to heating with buffer supplemented with increasing concentrations of 2-mercaptoethanol. This suggests that 5-HT %(a) contains exclusively S-ester-linked acyl groups and no fatty acids linked by an amide bond, which would have been resistant to such treatment. Furthermore, after treatment of gels containing fatty-acid-labelled 5-HT %(a) protein with neutral hydroxylamine, hydroxylamine cleaved the [$H]palmitate-derived label from the receptor, whereas labelled lipids remained unaffected ( Figure  2B ). This sensitivity to neutral hydroxylamine and reducing agent indicates that fatty acid is bound to 5-HT %(a) via an S-estertype linkage.
To prove the identity of the actual protein-bound fatty acids in 5-HT %(a) protein after labelling with [$H]palmitic acid, receptors were subjected to fatty acid analysis. Fatty acids were hydrolysed from gel-purified 5-HT %(a) and separated into the individual fatty acid species by TLC. Radiochromatographic scanning of the TLC plates (Figure 3 ) revealed that 5-HT %(a) contained pre- Figure 3 Chromatographic identification of receptor-bound fatty acids dominantly palmitic acid, with traces (less than 1 %) of myristic acid.
Activation of 5-HT 4(a) induces changes in its palmitoylation
To test whether the incorporation of [$H]palmitate into 5-HT %(a) is promoted by agonist, we performed experiments with Sf 9 cells expressing 5-HT %(a) protein. Cells were incubated for 60 min in the absence or presence of increasing concentrations of BIMU8, a 5-HT % receptor-selective agonist [21] . Levels of radiolabel incorporated were evaluated from fluorograms of SDS-containing gels after the immunoprecipitation of 5-HT %(a) . As shown in Figure 4 , BIMU8 generated a dose-dependent increase in the labelling intensity, with an EC &! of approx. 10 nM. The change in receptor labelling after stimulation with agonist was not due to any general metabolic effects because the incorporation of [$H]palmitate into total membrane proteins was not affected by treatment with agonist ( Figure 4C ). It should also be noted that stimulation with agonist did not increase the amount of newly synthesized receptor. Indeed, as seen in the inset to Figure 4 (A) and in Figure 4 (C), the incorporation of [$&S]methionine into 5-HT %(a) as well as into total membrane proteins was even decreased slightly after the application of agonist. In general we obtained a 5-15 % decrease in protein synthesis after stimulation with agonist, depending on the experiment. Thus the absolute increase in the rate of palmitate incorporation was approx. 3-fold after stimulation with 100 nM agonist. In all subsequent experiments the BIMU8 concentration was kept at 100 nM.
To exclude further the influence of possible changes in the rate of receptor synthesis on palmitoylation, receptor-expressing cells were labelled with [$H]palmitate or [$&S]methionine in the absence or presence of cycloheximide. The resulting fluorogram ( Figure 5) shows that despite the block of protein synthesis, 5-HT %(a) still incorporated palmitic acid and the increase in its radiolabelling was promoted by agonist. These results demonstrate that fluctuations in receptor synthesis cannot account for the above observations. In addition, these results emphasize the post-translational nature of palmitoylation and indicate that Regulated palmitoylation of mouse 5-hydroxytryptamine 4(a) receptor immunoprecipitation and SDS\PAGE. As shown in Figure 6 (control), the intensity of radiolabelling of the receptor increased steadily, reflecting a basal turnover of palmitate. To determine whether the activation of receptor influenced its palmitoylation state, the kinetics of [$H]palmitate incorporation was studied in the presence of BIMU8. The results shown in Figure 6 reveal that exposure to BIMU8 significantly increased radiolabel incorporation into the receptor over the whole labelling period of 120 min. On average, BIMU8 elicited an approx. 2.5-fold increase in labelling in comparison with controls. Labelling with [$&S]-methionine showed that exposure to agonist slightly decreased the amount of 5-HT %(a) protein (results not shown), demonstrating that the real increase in the rate of palmitate incorporation into receptor was even more pronounced, as seen in Figure 6 (B).
To establish the specificity of agonist-promoted palmitoylation of 5-HT %(a) , infected Sf 9 cells were labelled with [$H]palmitate for the same durations in the presence of GR113808, a high-affinity 5-HT %(a) antagonist [32] . Treatment with GR113808 alone significantly decreased the incorporation of radiolabel at all periods in comparison with agonist-treated or control cells ( Figure 6) . Interestingly, the quantity of receptors was unaffected, as tested by labelling with [$&S]methionine over the period studied (results not shown). Because it has been reported that unstimulated 5-HT %(a) possesses a high constitutive activity [27] , the decrease in palmitoylation obtained might have resulted from an inhibition of basal agonist activity by antagonists. When cells were treated with GR113808 and BIMU8 during the period of labelling, the time course of palmitate incorporation was similar to that obtained in the control (results not shown). Taken together, these results demonstrate that an agonist-dependent increase in palmitate incorporation into 5-HT %(a) is due to receptor activation rather than reflecting changes in the rate of receptor synthesis.
To determine whether the agonist-promoted increase in receptor palmitoylation resulted from an elevation in the stochiometry of acylation or reflected a faster exchange between labelled and unlabelled palmitate, pulse-chase labelling experiments were performed. Infected Sf 9 cells were incubated with [$H]palmitate for 60 min followed by incubation with 100 µM unlabelled palmitate and 5 mM sodium pyruvate in the presence of either BIMU8 or BIMU8 plus GR113808 for various durations. As seen in Figure 7 
DISCUSSION
In this study we present evidence that 5-HT %(a) expressed by the baculovirus system is covalently modified by palmitic acid. The fact that the label is sensitive to reducing agents, as shown by treatment with 2-mercaptoethanol and hydroxylamine (Figure 2 ), indicates that fatty acids are attached through an S-ester linkage to the free thiol group on one or more cysteine residues.
Palmitoylation of GPCRs seems to be a general feature of these signalling molecules ; approx. 80 % of all known receptors contain one or more potentially palmitoylable cysteine residues downstream of their seventh transmembrane domain [32] . The roles of receptor palmitoylation have been investigated mainly by functional approaches involving acylation-deficient mutants [33] . However, the regulation of receptor palmitoylation in response to receptor stimulation has been addressed sporadically but has not yet been reviewed critically. The results of experiments presented here demonstrate that the palmitoylation of 5-HT %(a) is a dynamic process that can be modulated by agonists. The use of both incorporation and pulse-chase approaches allowed us to distinguish between two possible reasons for this modulation : (1) an increased proportion of palmitoylated receptors or (2) an enhanced exchange of receptor-bound palmitate. The results of incorporation experiments demonstrate that the increase in palmitoylation most probably does not result solely from the acylation of newly synthesized receptors because the rate of agonist-promoted palmitoylation was approx. 3-fold higher than
